https://www.selleckchem.com/pr....oducts/CP-690550.htm
Third, patients 60 years of age or younger with a patent foramen ovale (PFO) should be carefully evaluated to determine whether the PFO may have caused the stroke and whether they might benefit from PFO closure. SUMMARY More personalized strategies may soon be available to guide treatment of cryptogenic stroke. In the meantime, it is hoped that the application of recent findings from clinical trials will reduce stroke recurrence in this important population.PURPOSE OF REVIEW This article reviews the clinical significance and neuroimag
Me gusta
Comentario
Compartir
